Exogene is a company headquartered in the United Kingdom.
Exogene is a techbio startup developing AI-driven discovery platforms to identify novel T-cell receptors for use in TCR-based cancer immunotherapies targeting solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.